Annual Drug Patent Expirations for CRESEMBA
Cresemba is a drug marketed by Astellas and is included in two NDAs. It is available from one supplier. There are three patents protecting this drug.
This drug has twenty-nine patent family members in nineteen countries.
The generic ingredient in CRESEMBA is isavuconazonium sulfate. One supplier is listed for this compound. Additional details are available on the isavuconazonium sulfate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
